Top Kidney Researcher: I Found The Reason Why Your eGFR Keeps Declinin – Rovina
The two chiefs
House chief · 6/10
advertorial on the seller's own store · cold paid-social traffic, first touch, clicking through to the product page · adults of roughly 55 to 75 with a kidney panel trending down while on blood pressure medication · problem-aware, not yet solution-aware · one oxidative cause behind three signs, answered by a membrane-spanning antioxidant at 12 mg in its natural form
Lead: A problem-solution lead with a story inside it, grade B plus. The mirror (7 to 9) and the forum discovery (10 to 15) are excellent; the headline is too long, and its authority label is a claim the body itself contradicts.
Offer: The weakest element, grade D: no price, no bundle, no anchor that holds, one bonus, a percentage with nothing to measure it against. The page hands the whole offer to the product page.
Close: Over-built, grade C plus: three closes and six buttons in the last quarter, a guarantee stated twice with different terms, scarcity with a typed-in count. The dated self-test (50) and the letter (66 to 71) are the two parts that earn their place.
Throughline: Holds emotionally from dread to relief and sags twice: in the origin story (33 to 35), which is thin, and between entries 60 and 65, where blocks repeat. It recovers in the letter.
Strongest
- one cause mapped onto the reader's own three signs, in the reader's order (7, 19, 22 to 25)
- the doctor conceded, the target moved (20)
- the ingredient introduced through the narrator's own failed purchase and doubt (28, 29)
- the results ladder told twice, the second time as the reader's dated test with a refund at each date (50)
- the brand first named inside its guarantee (47)
Weakest
- no offer on the page: no price, no bundle, a discount with no base (48, 73)
- first button at 76 percent, then six in a quarter of the page, three with one label (55 to 76)
- figures that contradict each other (16 against 48; 42 against 66; 37)
- a narrator with four incompatible roles, exposed by the third-person slip (62) and the signed buyer's letter (71)
- proof that is all arithmetic: no named person, paper or lab (17, 45, 33)
Craft chief · REVISE
Read aloud, the first fifth sounds like one frightened person typing at night and pulls hard; from the science block on it sounds assembled, the same cadences return on schedule, and the figures stop agreeing with each other.
Strongest
- entry 20: keeps the doctor right and moves the blame to the target, in one quoted verdict and a two-word concession
- entry 41: a result told as a non-event, witnessed by a husband who noticed nothing
- entry 50: the timeline handed to the reader as a dated self-test with a refund at each date
- entry 68: the staircase scene, sentences that stop where she stops
- entry 31: the molecule paragraph, whose long last sentence stretches like the thing it describes
Weakest
- entry 62: a paragraph in the third person and two recycled lines
- entry 48: an anchor that contradicts entry 16, and a sentence with its end missing
- entry 13: the section opens by repeating the line before it
- entry 37: a dose that contradicts itself in eight words
- entry 61: a refund statistic nobody could believe
001 PASS·noted: entries 7 to 15 move well on short lines of falling length; entries 22 and 23 share one skeleton, and the closing section is fragment after fragment with no plain connective sentence between the hits. · 002 PASS·noted: attention (3, 4), interest (10 to 15), desire (38 to 42) and action (55 on) are all present, in an order that fits a problem-aware reader; the close is finished three times over (46, 54, 64) and the first button waits until 76 percent. · 003 PASS·noted: plain words almost throughout; the science block adds two technical terms, both glossed in their own sentences (19, 23); the extra marker in entry 50 and the saturation idea in entry 32 are left bare. · 004 REVISE: entry 13 restates the last line of entry 12 across two rows, entry 62 repeats two lines of entry 45 unchanged, and the text never says where the ingredient came from before she is buying it in entry 28. Cost: each seam tells the reader the page was assembled, and the slide stops. · 005 REVISE: the headline's rank (entry 3) and the deck's study of 41,847 people (entry 5) are paid off as a patient reading a forum thread (10 to 13) who needs a researcher's help (33). A reader who took the hook literally is tricked. Cost: trust, at the moment the product is introduced. The loop about the reason itself is honestly closed (15, 19). · 006 PASS·noted: the page is rich in things a reader can point at (ankles by evening, the saved photograph, two flights of stairs, the confirmation email) and the scarcity has a reason-why (34, 58). The 67 percent in entry 73 has none. Exact figures are noted for the claims check, not judged here. · 007 PASS: one phrase is highlighted in each subhead and the two-word verdict in entry 7 is bold; the emphasis falls where a voice would stress. · 008 PASS·noted: stock phrases recur (the total-change line at 17, 36 and 37; the two-word refrain five times; the no-questions line three times). Each costs little alone; together they read as filler. · 009 PASS: the story lead opens a loop at entry 10, sets one scene with one object (the thread, the numbered comment, the long stare) and closes it at entries 56 and 64. · 010 PASS·noted: contractions, fragments and openers on And or But throughout; three lines no person would say (the adverb in entry 67, the broken anchor in 48, the coined tiredness phrase in 40). · 011 PASS·noted: headline and hero work as one argument (3, 4). The turning-point comment is shown as a picture and restated in text (13, 15), so it is not trapped, but all 22 pictures carry empty alt text and the ingredient's introduction may exist only inside a picture. · 012 PASS·noted: the ordering steps (49) give real care to a neglected surface, down to the spam folder. Breadcrumb, badge labels and image alts are theme defaults (2, 74, 75), and three buttons share one label. · 013 PASS: the reader's fear is named in their own terms (the dread taken into each visit in 9, the hesitation over the button in 66, the exception fear in 70). · 014 PASS·noted: the arc holds (dread, crowd, cause, absolution, attempt, result, invitation) and the letter gives release; the character does not hold, since one name is researcher, patient, maker and buyer by turns. · 015 REVISE: dashes run through entries 19 to 32 and the offer section (27 rows in all); the deny-then-assert flip sits in 22 and 23; mirrored sentence pairs end both; setup frames open 49 and close 52. Cost: the first-person voice is the page's proof, and these cadences tell a practised reader it was generated. · 016 PASS·noted: the two lab words in the headline are the reader's own; the cell term and the inflammation signal are glossed in their sentences (19, 23). The extra marker in entry 50 is named without a gloss. · 017 PASS·noted: emotion (despair), curiosity gap (a reason exists) and stakes (the falling score) are all in the headline, and the loop is paid. The rank in the label is not (see 005). · 018 PASS: the colour is real and felt: the numbered comment, the husband who noticed nothing, the saved photograph, the text to the sister. · 019 REVISE: the signature is the proof and it breaks. Lines left from a page about a habit (8, 12, 20), a paragraph in the third person (62) and a buyer's letter signed by the maker (66 to 71) show that no one person wrote this. Cost: the reader who notices discounts every first-person claim. The imperfect beat in entry 29 is the exception, and it is shared with the skin page. · 020 PASS·noted: a single-page pass cannot audit the site, but the local copies show it: 35 of this page's text rows are word for word the same as the store's skin page, including the closing letter. One buyer who meets both pages sees the clone. · 021 N/A: no email sequence in scope. · 022 PASS: every REVISE above names its cost; sharp lines a mechanical read would flag are kept (the claim that nothing is being sold in 14, the marketplace line in 53, the three-word close in 56). · 023 N/A: a delayed reveal is the chosen architecture for a story page; the object is withheld on purpose until entry 47. (The breadcrumb in entry 2 names it anyway.) · 024 PASS·noted: the absolute promise in entry 43 is qualified by the one hedge in entry 50 and by the instruction to stay on medication (49, 51); the surface contradicts itself on how sure the outcome is. · 025 PASS·noted, for the claims check: baseline 41 (42) against 39 (66, 69); 22,000 dollars (16) against 14,000 (48); eight years on the drug (20) against six (69); two softgels against one (37); a ninety-day window with day 100 inside it (60); jar against bottle (49, 47); sixty results from forty people (45).
Take
- Crowd before narrator: the hero and the first turn show many people with the same unanswered question before anyone explains anything (4, 10 to 12). Social proof of the problem costs the reader no belief.
- One cause mapped back onto the reader's own list: the mirror names three signs (7), the cause block explains the same three in the same order (22 to 24), one line compresses it (25), and each past remedy is then failed by that line (27).
- Doctor right, target wrong (20): the physician's verdict is quoted and conceded, so the reader never has to choose between the page and their doctor.
- The ingredient enters through its own failure (28, 29): the narrator buys the shelf version, feels nothing and doubts herself. The reader who has tried it is met first, and dose and form become the test (30, 32).
- The place of harm is set up before the molecule (19, 22, then 31): the membrane is named twice as where the trouble starts, so the membrane-spanning molecule arrives as the fit.
- The timeline told twice: once as her story by date (38 to 42), once as the reader's calendar with a way out at each date (50).
- The ordering steps (49): today, two days, on arrival, down to the confirmation email and the spam folder, written for an older buyer.
- A result told as an absence, with a witness (41), and a private sign turned into an exhibit (40).
- The brand named first inside the guarantee (47), at 63 percent, after the reader has agreed to a path (46).
- The callback close: the opening crowd returns with the reader moved from lost to found (56).
- The fear of being the exception answered by agreement, in four words (70).
- Proportions: story to 17 percent, cause to 33, ingredient and maker to 47, results to 58, proof and guarantee to 65, practical to 72, closes to the end. A quarter of the words go to closing.
- One highlighted phrase per subhead, so a skimmer reads the argument from the subheads alone.
Leave
- Every disease word and outcome: the two lab markers, the stage, dialysis and the referral, protein in urine, a score that rises, swelling that clears, the promise to end the dialysis talk for good (3, 5, 7, 42, 43, 47, 50, 54, 69).
- The invented authority: the researcher title, the white coat in the portrait, the ratings count on an article (3, 6). CL-14.
- The invented crowd, whose one number is used as four different things (5, 10, 46, 61, 64), and the other made-up counts: 4,237, 5,847, 40, 60, 4,000, 847, 2,400, 147, 127, two refunds.
- Fabricated evidence: the staged forum posts and comment (4, 13), the paper that is never named (17), the lab values and the quoted kidney doctor (42, 69).
- The lab-visit origin story and the carrier-oil argument (33, 34); carrier superiority is banned for us (b8).
- Typed-in scarcity, the availability buttons and the page-only bar (1, 53, 58, 59).
- The template seams: lines from a page about a habit (8, 12, 20), the paragraph in the third person (62), the buyer's letter signed by the maker (66 to 71), the dose that says two and one (37), jar and bottle, 22,000 and 14,000, 41 and 39.
- Their terms: ninety days (ours is the 30-Day Money-Back Guarantee), a subscription (we have none), bottles kept in one place and taken back in another.
- The layout that lets a delivery time read as a result time (63).
- A refund tied to a lab result (47, 50): a promise of outcome.
- The machine cadences: dashes, the deny-then-assert flip, mirrored closers, the two-word refrain (22, 23, 37, 52).
- Six buttons in the last quarter and none before it; three with the same label.
- For this angle, any line that sets a prescription up as the wrong tool (the gate's r4 is not needed here). Our reader stays on what her doctor gave her, and the page says so once.
Line by line · 76 entries
Every line is described in our words; the page's own text stays on the page (open it beside this table). Shaded rows carry the most pull.
| # | Beat | What the line does | Lever · reader | Why here | Craft | On our page |
|---|---|---|---|---|---|---|
| 1 0.0% | page-furniture fine · 9 w | A full-width bar above everything announces a deal with a time limit, open only to visitors who arrive through this one address. | exclusivityurgency problem-aware | It sits above the headline because it needs no belief to work: a reader who has been told nothing can still register that leaving costs something. Lower down it would read as a pitch interrupting a story; up here it is wallpaper that only pays off when the discount is finally stated in entry 73. | Eight words in capitals split by a bar: no verb, no figure, no deadline. It promises a limit without saying what the limit is, and it tells a reader who came for an article that the article is a sales page. | page-furniture The house launch banner goes in this slot (launch week, the code, the real countdown). No page-only wording unless the price truly differs by page. |
| 2 0.3% | page-furniture fine · 9 w | A store breadcrumb runs from the home page through a kidney health category to the product, which it names together with the brand. | none problem-aware | A theme default, not a decision: the page is built on the store's own chassis, so the trail prints at the top. The effect is an accident worth noting. A reader who glances at it meets the product at 0.3 percent of the page, which undercuts the slow reveal that entries 28 to 47 work to build. | Grey, small, seven words and two arrows. Nobody wrote it. It is the one place where the page admits what it is. | page-furniture Our prelanders sit on an editorial chassis whose section crumb (Healthy Aging, Kidneys) names no product. The product stays off the first screen. |
| 3 0.4% | hook-headline h2 · 23 w | A red authority label, then a first-person claim to have found why a filtration score keeps falling and a waste marker keeps climbing in people whose blood pressure pills are working, closing on the reader's own despair. | curiosity-gapmirroringspecificityearned-authority problem-aware | It is read first, so it has to qualify and promise in one breath. It assumes only what the reader already holds: a lab sheet with two figures moving the wrong way and a doctor who calls the prescription fine. By naming a reason without giving it, it buys the next seventeen percent of the page, which is all story and no science. | Twenty-three words, far too long for a headline, with a grammar slip in the second lab verb. It works anyway because the nouns do the targeting: two lab markers and one drug class. The label in red asserts a rank with nothing behind it, and the body later contradicts it (in entry 33 the narrator needs a researcher's help). | rewrite-claim The CS-A03 hook in page register: kidney numbers drifting, the doctor said watch it, so she did. Recognition in her words plus the outcome (CL-06). No lab abbreviations, no drug class, no rank we cannot show (CL-14). r10 |
| 4 1.3% | image img | Hero picture, seen in the local capture: a dark collage of eight forum posts from kidney communities, each a stranger saying blood pressure is under control while the kidney figures keep sliding, with vote and reply counts. | consensusmirroringidentification problem-aware | Directly under the headline and above the deck: the reader has been promised a reason and is first shown that many others carry the same unanswered question. Between them the eight posts preview every argument to come (pressure fine yet figures falling, diet advice failing, three troubles at once, fear of the referral), so each later beat feels already heard. Shown after the story began it would be decoration; shown first it is the premise. | Fabricated posts: the handles are built from the complaint plus an age and every card shares one styling, so these were made for the page. The central card is set larger and works as the collage's own headline. As a device it is strong because it is social proof of the PROBLEM, which costs nothing to believe. No alt text. | drop No invented posts. The hero is the CS-A03 scene: a hand writing a recheck date on a chart, or a lab printout with the values blurred beside reading glasses, no figures visible. Real customer words only when they exist and are cleared (the panel in r17 is pending). r10 |
| 5 2.3% | deck p · 27 w | A highlighted first sentence says everyone failed for one shared cause; the narrator then claims to have studied 41,847 people at a named stage of kidney decline and seen what two kinds of specialist overlooked. | vindicationspecificityearned-authoritycommon-enemy problem-aware | Between the crowd picture and the byline: the picture has just shown many people, so a count of them is ready to be believed, and the byline that follows needs a reason to be listened to. Absolution is offered before a single symptom is described, which lets the reader lower their guard for the mirror in entries 7 to 9. The two specialists are named here so that the later correction of the doctor (entry 20) feels promised. | The number is the page's motif and it is invented: it returns as a forum headcount (entry 10), a customer count (46), a refund denominator (61) and a place in a queue (64). The verb claims a study; the body delivers a woman reading a thread. Title case on every word makes 27 words hard to read. | rewrite-claim The deck carries the reframe (CL-06): what protects kidney cells is fat-soluble and reaches the cell membrane, so it is not extra work for the kidneys the way a water-soluble multivitamin is. No head count, no disease stage, no specialist as the foil. r10r26m2 |
| 6 3.0% | authority-stamp 3× p · 19 w | Five stars and 4,237 ratings, then the byline: a woman's name, a title of eight-year kidney health researcher and educator, a city, a 2025 date, a green tick. Her portrait (seen in the capture) wears a white coat and stethoscope. | earned-authoritysocial-proof problem-aware | Straight after the deck's claim of a study, because a claim of that size needs a face at once. The reader must already want the reason to exist; the stamp lets them believe someone qualified found it. It also has to precede the first-person lines, since from entry 8 on the voice is a patient's and would otherwise have no standing. | Invented authority. The words stop short of a medical title while the portrait dresses her as a clinician, so the picture makes the claim the text avoids. The green tick beside the title copies a platform's badge for verified accounts and verifies nothing. A ratings count belongs to a product, not to an article, and no product has been named yet; the same count stands on the skin page. The date is seven months older than the stock notice in entry 73. | rewrite-claim No invented expert (CL-14). The byline is the narrator as a customer in her sixties, a composite disclosed in the footer, or an editor's byline as on CS-P1. A doctor's recommendation appears only through the operator-confirmed advisor, once. No ratings count until real reviews exist. r19 |
| 7 3.7% | symptom-mirror 4× p · 36 w | Four clipped lines with no subject: the score falling each year on a drug the doctor approves of, the waste marker climbing with it, ankles puffy by evening, the dialysis talk drawing nearer, then a two-word verdict in bold. | mirroringspecificityfear-of-decline problem-aware | First lines of the body: the headline named the markers, so the body opens by repeating them as lived facts and adds the one sign a person can see at home. No subject is given, so for four lines the reader cannot tell whose chart this is and assumes it is their own. Only after that agreement does the narrator step in, at entry 8. | Fragments of 14, 12, 8 and 2 words: each line shorter than the last, a staircase down to the verdict. The physical sign is the only picture in the block; the rest are lab words. The fourth line is an absolute, and the page will spend its length taking it back. | rewrite-claim The same staircase in CS-A03's words: the numbers drifting, feeling fine, the visit that ends with keep an eye on it, the re-test six months out. Her experience only: no dialysis, no stage, no drug named as failing. r10 |
| 8 5.0% | symptom-mirror 4× p · 39 w | The narrator arrives in the first person: she could not see the cause, she had followed every rule, she felt marked from birth, and she says no outsider grasps how the condition swallows a life. | identificationmirroringvindication problem-aware | After the chart has been agreed, not before: a stranger's feelings are of no interest until the reader knows the stranger has the same figures. The line about having followed every rule plants the absolution that entry 18 will pay. It also quietly swaps the promised researcher for a patient, which the reader accepts because the feelings are accurate. | Short declaratives, one feeling each. Two of them do not fit a kidney story: shame about being made wrong belongs on a page about a habit or a body, and the same lines, with the organ swapped, stand at these rows on the store's skin page. The switch to the second person in the last line is the best move here: it hands her feeling to the reader. | keep-structure The felt cost in a senior's voice: the six months of wondering, reading the printout in the car, not wanting to worry the children, wanting to stay independent. No shame language; nothing is wrong with her. r24r10 |
| 9 6.0% | symptom-mirror 3× p · 45 w | She sets the outsider's view of a figure on paper against the dread she took into each visit, names the tiredness of living between bad results, and says she spent eight years that way. | identificationcontrastspecificity problem-aware | Last beat before the hinge. The reader has agreed on the chart and on the feeling; what is still missing is time served, because a discovery only matters if the search was long. Eight years makes the crowd in entry 10 a relief instead of a statistic. | The longest sentence of the story so far (22 words) carries the contrast and lands it on the appointment. The third line reads as a reply to someone else's words, as if the lines above had been a quotation: a seam left from the template. | keep-structure The wait named in her terms: the gap between two panels, the calendar six months out. A count of years only if the narrator's composite is written that way and disclosed. r10 |
| 10 7.0% | turning-point 2× p · img · 10 w | A one-word hinge on its own line, then the find: 41,847 people in the same torment. A picture follows (not in the local capture; by position, the forum thread with its size showing). | pattern-interruptconsensusreliefstory-transport problem-aware | At seven percent, once the mirror is complete and before any explanation. The reader has to feel alone for the crowd to land, which is why the feelings came first. The crowd in turn is what makes the coming comment worth reading: advice from inside the group, not from a seller. | The hinge is a single word with an ellipsis, the oldest trick in the sales letter and still effective. The count repeats the deck's number and quietly changes its meaning, from people she studied to people in a thread. The strong noun that ends the sentence is the first heat in the prose. | rewrite-claim Our hinge turns on what she read, not on an invented crowd: most people her age have never heard of astaxanthin and think their pill drawer is complete. A head count appears only as a real four-digit customer number (CL-11). p7 |
| 11 8.4% | turning-point 2× p · img · 27 w | She opens the thread braced for the standard three tips on salt, water and protein, and finds a multitude of strangers describing it in the very phrases she uses. A picture follows (not in the capture; by position, those posts). | story-transportmirroringconsensuscommon-enemy problem-aware | Right after the crowd is announced the reader needs to see inside it. Naming the three stock tips first tells the reader this page will not repeat them, which is the permission they need to keep reading. The shared vocabulary sets up the question of entry 12: why would strangers all put it the same way. | A small scene with an expectation and a reversal in two lines. The tips come as three three-word imperatives, the way a tired patient would recite them. The picture carries the proof and the text only points at it. | rewrite-claim The stock advice she is tired of becomes ours to name: drink more water, watch the salt, come back in six months. No forum. What she finds instead is the idea that her vitamins stay in the bloodstream and never reach the cell. r5p3 |
| 12 10.3% | turning-point 4× p · 42 w | Members differ in habits yet describe the feeling identically; she insists the match is word for word, says a cause lies behind it, and points to comment 5,847, deep in the thread, as the explanation for every failed attempt. | open-loopcuriosity-gapspecificityreason-why problem-aware | The crowd has been shown; now it has to mean something. If everyone uses the same words, one cause must be behind them, which is the page's whole argument in miniature. The comment number makes the coming answer feel found, not written, and the reader will not leave before seeing it. | Four lines of 15, 6, 6 and 15 words: long, short, short, long. The second line corrects the first, a spoken habit. The comment number is the most believable detail on the page precisely because it is useless; it is also a template constant, since the skin page cites the same number in another thread. The first line's talk of behaviours is another leftover from a page about a habit, not an organ. | keep-structure Keep the move of one cause behind several complaints: tired by noon, foggy, stiff, numbers drifting, and one reason under all of them. The loop opens on a question she can carry: why do the pills she already takes not reach the cell. No comment number. p3r5r3 |
| 13 11.9% | villain-reveal h2 · 2× p · img · 34 w | A subhead says she saw something baffling; two lines restate the comment and its promise almost as entry 12 did. Then a picture (not in the capture): judging by the echo in entry 15, the comment itself, blaming oxidation. | curiosity-gappattern-interruptnew-mechanism problem-aware | At twelve percent the loop has been open for one entry, long enough to pull and short enough not to annoy. The cause is given to an anonymous member because by now the reader trusts the group more than any expert; the narrator only reacts. Everything after this point is explanation, so the reveal has to happen before the science block can start. | Fabricated: the comment is staged. The section opens by restating the previous paragraph's last line across two rows, a join between two template blocks that nobody smoothed (the skin page has the same join). The reveal itself lives in a picture with no alt text, so a reader whose images fail gets the reaction without the fact. | rewrite-claim The cause arrives in text, in one household comparison, before any term: ordinary antioxidants guard only part of the cell, and the inner membrane stays exposed. The source is named; no staged comment. p3r1 |
| 14 13.9% | villain-reveal 2× p · 23 w | She remarks that the comment stood alone, with no argument and nothing for sale, as if its author was worn out from repeating it, and that she looked at it for twenty minutes. | candorstory-transportspecificity problem-aware | Immediately after the comment, before its content is unpacked. The reader's first question about any claim is who gains from it; this answers nobody. Only then is the claim repeated, in entry 15. The length of her stare tells the reader to slow down too. | Five fragments, the fourth holding an ellipsis, then a plain sentence with a figure in it. Saying that nothing is being sold, inside a sales page, is the boldest line in the first fifth, and the rhythm carries it. | keep-structure Keep the pause: she reads the line twice and sits with it. The disinterested source must be real: a named journal, or an NIH or PubMed record shown as a screenshot (house prelander law), never a staged stranger. r14 |
| 15 14.5% | villain-reveal 3× p · 17 w | Three short questions repeat the comment's claim back in disbelief: that the filters are oxidizing, that this pulls the score down, and that it causes the swelling too, all in one process. | new-mechanismcuriosity-gapmirroring problem-aware | The picture stated the cause; the text now restates it as the narrator's doubt, so the reader is allowed to doubt with her instead of against her. It must come before the bill in entry 16, because that bill only stings once a different cause is on the table. | Questions of six, four and seven words. The first is addressed to a you although she is quoting it to herself: the pronoun was not converted when the comment was pasted into her voice. The closing words of the block carry the idea that will organise the next fifteen percent. | rewrite-claim Her questions in our terms: my vitamins never reach the cell? The same gap behind the tiredness and the numbers? Structure and function only, no disease outcome. p3r5r10 |
| 16 15.3% | failed-solutions 4× p · 34 w | She totals the past: eight years of changing what she ate, 22,000 dollars on two kinds of specialist, renal vitamins and low-salt food with dialysis already on the table, then asks whether diet and dose were ever the issue. | loss-aversionspecificityvindicationanchoring problem-aware | Placed after the new cause and before its proof. Earlier, the list would be a complaint; here it is a bill for a mistake somebody else made. The closing question hands the reader the conclusion to draw, which prepares them to accept a study in entry 17 without asking which one. | Years, dollars, then a three-item inventory in fragments. The dollar figure will not match the one in entry 48. The question that closes the block is long and clumsy, by design or by accident; read aloud it sounds like someone thinking. | rewrite-claim Her pill drawer instead of a medical bill: the multivitamin, the fish oil, the collagen, the things she juggles each morning. No dollar total we cannot source, no drug named as wrong. r23r3p7 |
| 17 16.7% | proof-study 2× p · 13 w | A time stamp in the small hours, the bare word for a scientific paper, and a stock line that what she read altered the course of things. No title, journal, year or link is given. | borrowed-authorityopen-loopstory-transport problem-aware | The comment gave the idea; an idea from a stranger is not enough to carry the long explanation that starts at entry 19. The paper is dropped in exactly between the doubt and the absolution so that the subhead in entry 18 can speak with certainty. It is never produced, so it has to pass quickly. | Fabricated by omission: a paper that cannot be named is a prop. The hour is the only concrete thing in the entry and does all the work. The second line is filler that the page reuses at entries 36 and 37. | swap-proof A real record in this place, shown as a screenshot with its identifier and a plain caption. Our research holds no human kidney trial, so the record is about how astaxanthin sits across the cell membrane, and the kidney line is worded as support, never as a trial result. m2r14 |
| 18 17.3% | villain-reveal h2 · img · 17 w | A three-part subhead clears her of blame, assigns the trouble to biology, and adds that she had not known how biology operates. Picture after (not in the capture; by position, a diagram of the filter cell). | vindicationreliefreason-why problem-aware | At seventeen percent the story stops and the teaching starts, and the reader will only sit through teaching if first told it is not an accusation. This is the payoff of the line about following every rule in entry 8. Later on the page it would be too late: the science block would read as a lecture. | The first two sentences are clean and short. The third takes back part of the gift by blaming her ignorance, and its grammar stumbles. One phrase is highlighted, as in every subhead on the page. | keep-structure Our subhead gives the same release without a culprit in a white coat: it was never her effort, her pills never reached the cell. The PDP's own subhead on this is the model. Doctors stay allies. p3r3r5 |
| 19 18.8% | mechanism 2× p · 75 w | The paragraph blames free radicals that outrun the body's defences at the membranes of the kidney's filters, traces the harm inward, and lists the opening's three signs as its output. She adds that she had been treating a figure. | new-mechanismreason-whyloop-closedmirroring problem-aware | First paragraph after the absolution, because the reader now wants the how. It returns the three items of entry 7 in the same order, so the explanation feels fitted to their chart and not lifted from a textbook. With the cause fixed at the membrane, the page has prepared the one place its product will later claim to reach (entry 31). | Sixty words, nearly three times the length of any line in the story, yet built from short clauses. The technical noun is glossed inside dashes in the same sentence. Her one-line summary after it uses a rust verb that the page keeps for the rest of the block. | swap-mechanism The Cell Shield's problem side: unstable oxygen from modern diet and modern life wears on the cell membrane, and ordinary antioxidants cover only part of it. One household picture (rust), kidneys named first. Signs are described as hers; no lab marker is promised. r1p3r10 |
| 20 20.3% | dismissal-by-authority 2× p · 59 w | She says nothing she tried got into the cell and clears herself of blame. The drug is then judged: it held her readings eight years, the kidney doctor called it optimal and was right, yet the score fell; wrong aim. | vindicationcontrastreason-whycandor problem-aware | It follows the cause at once because the reader's first objection is their own doctor: if this were true, the specialist would have said so. The page answers by agreeing with the specialist about the drug and disagreeing only about the target. That concession is what lets entries 49 and 51 later tell the reader to stay on their prescription without contradiction. | The doctor's quoted verdict is followed by a two-word sentence conceding it, the most disarming moment in the science block. The closing two-word fragment is the argument in miniature. The denial of idleness has no business in a kidney story and is a template leftover. | keep-structure Doctor as ally, in exactly this shape: watching the numbers is right, and between two panels there is one thing she can do that her pills do not. The gate holds a line about prescriptions masking symptoms (r4); this angle reads better without it. The medication question is answered in the FAQ. r10r28p3 |
| 21 21.7% | mechanism h2 · 10 w | A subhead announces that the oxidative harm was driving three things at once, and ends on a colon. | open-loopnew-mechanismspecificity problem-aware | The cause has been stated once in prose; a reader who skims needs it as a structure. Three is the count of signs in entry 7, so the list promises to explain each of the reader's own complaints in turn. It must precede the audit of remedies (entries 26 and 27), which borrows its logic. | Ten words and a colon. The verb treats the damage as an engine running programs, a metaphor from another trade that the page returns to again and again. | keep-structure Our numbered three, organs explicit in the subhead (CL-04), kidneys first: kidney numbers, the noon crash, the fog. One cause under all three: a cell membrane left unguarded. r10r7r6p3 |
| 22 22.3% | mechanism h2 · p · 96 w | Item one pairs membrane oxidation with the falling score: each filter cell sits in a delicate membrane where harm begins, corroded filters cannot clear the blood, food protein is not to blame, and the drug relieves pressure only. | new-mechanismreason-whyvindicationcontrast problem-aware | First of the three because the score is the figure the reader fears most and the one the headline named first. It has to come before swelling and tiredness, which the reader ranks lower. It also repeats the membrane as the place of harm, a second rehearsal for entry 31. | Eighty-nine words, the longest paragraph on the page. It ends on a mirrored pair of short sentences, drug against damage, and item two ends the same way: a mould, visible by the second use. The turn that denies one cause and asserts another after a dash appears here and again in item two. The capital header names cause and result with nothing between them (the skin page's headers have a dash there). | rewrite-claim Pillar one: kidney cells. Astaxanthin is fat-soluble and is taken up into the cell membrane, so it supports kidney cells without adding to what the kidneys must flush. Steadier numbers as the hope; no score promised. r10r26m2 |
| 23 24.8% | mechanism h2 · p · 92 w | Item two pairs inflammation with swelling: stress switches on a signal named by its lab abbreviation, the kidneys stop clearing fluid, it pools in ankles, face and legs; salt and age are excused, the water pill works from outside. | new-mechanismreason-whyvindicationcontrast problem-aware | Second because swelling is the sign the reader sees daily, and the results section will lead with it (entries 38 and 39). Explaining it now is what makes the early results believable later. It needs item one before it: its opening adjective only works once a first effect is on record. | Eighty-six words on the identical skeleton: cause, consequence, excuse for the reader, mirrored pair to close. The lab abbreviation is glossed in the same sentence, so a stranger can follow. Three places on the body give the reader somewhere to look. | rewrite-claim Pillar two in our gate: chronic inflammation, and the tired, puffy feeling described as hers, with no fluid or swelling outcome promised and no drug demoted. r12r1 |
| 24 27.1% | mechanism h2 · p · 72 w | Item three pairs returning waste with tiredness: damaged filters let through what ought to have been removed, clean blood is dirtied again, exhaustion becomes the normal state, rising in step with the other two from one shared source. | new-mechanismreason-whymirroring problem-aware | Last because tiredness is the least specific and the most universal: by the time the reader reaches it they have accepted the cause twice and will grant the third without proof. Its final sentence gathers all three, which hands entry 25 its summary. | Sixty-seven words, shorter than its siblings, with no excuse line and no mirrored close, which makes it read the most naturally. One four-word sentence in the middle is the best in the block. The poison wording is stronger than anything a careful brand could print. | rewrite-claim Pillar three: energy with no crash by noon, felt in weeks one to two, and a clearer head. Described as cellular energy, never as waste or toxins in the blood. r7r13r6 |
| 25 29.1% | mechanism p · 34 w | A four-beat summary counts three worsening markers against a single fire behind them, says they move together, and explains their resistance to separate drugs by the fact that no drug reached the stress at its source. | reason-whycontrastspecificity problem-aware | End of the teaching, thirty percent in. The reader has been given a lot; they need it small enough to carry into the next block, where each remedy is judged by this one sentence. Without it, entry 27 would have to explain everything again. | Three, one, three, three: counted fragments, then a single long clause. The contrast of numerals is the bar-stool version of the page and the best-made sentence in the science. Its last words place the source above, although the block had it underneath. | keep-structure Our one-line version: several complaints, one unguarded membrane, and one softgel that reaches it. No claim that separate medicines fail. p3m2b9 |
| 26 30.1% | failed-solutions h2 · img · 6 w | A subhead promises a list of what failed together with the reason. A picture follows (not in the capture; by position, the three remedies as bottles or as a struck-out row). | open-loopreason-why problem-aware | Straight after the one-line summary, so every remedy can be measured against it. The reader has to hold the cause first; judged earlier, these would simply be products that had not helped her. Placed here they become confirmations of the cause. | Six words, a dash and a colon. It promises the why, which is what separates it from an ordinary list of complaints. | keep-structure Same subhead job. The picture is her own drawer: a multivitamin, fish oil, collagen, photographed without logos (no trademarked packs). p7 |
| 27 31.2% | failed-solutions 3× p · 65 w | Three verdicts, one each: renal vitamins fed the organ while membrane oxidation went on; cranberry quieted a single symptom and missed the cause behind all three; water pills drain fluid briefly, and the inflammation behind it carries on. | reason-whyvindicationcontrastobjection-preempt problem-aware | The reader has one or more of these in a cupboard. Each is granted a partial effect first, so nobody is told they were foolish, and each is then failed on the same ground. That leaves a product-shaped hole: something that reaches the membrane. Entry 28 walks into it. | Each verdict grants, then withdraws. The first ends on a good image of feeding a thing that is rusting away. The third ends by calling the process a mechanism, a lab word in a patient's mouth. Cranberry is a urinary-tract remedy more than a kidney one, a loose fit for this reader. | rewrite-claim Our three: the multivitamin (water-soluble, underdosed, stays in the bloodstream), vitamin C and E (guard only part of the cell), the energy drink or protein shake (adds to the load). Each is granted what it does, then shown where it stops. r3p3r25r26 |
| 28 33.2% | failed-solutions h2 · 3× p · 36 w | A subhead says she went to buy the exact remedy and found none. Next morning she ordered every astaxanthin product going, two low strengths and the synthetic kind, for a hundred dollars. First naming of the ingredient. | candorstory-transportspecificityopen-loop problem-aware | At thirty-three percent the reader has a cause and a gap. Naming the ingredient through a failed purchase does two things no plain reveal could: it meets the reader who has tried astaxanthin before, and it makes every bottle on a store shelf the wrong one before a better one is offered. It needs entries 26 and 27 first, since it is the fourth failed remedy in the same form. | The ingredient arrives with no introduction at all: the text never says the paper named it, so unless a picture did, the reader is simply expected to follow. The subhead's second sentence is three words. The spend is small and round on purpose, against the large odd figures elsewhere. The same subhead and the same spend stand on the store's skin page. | keep-structure Keep the move: she buys what the aisle sells first. The ingredient is introduced in a sentence before she shops (the red pigment from microalgae). What she finds on shelves: 4 to 6 mg softgels and synthetic product. b7c4r16c1 |
| 29 34.6% | objection 4× p · 25 w | She admits she felt nothing worth reporting, asks herself whether her theory is mistaken, returns to the paper, and says that was the moment the working version turned up. | candorobjection-preemptidentificationopen-loop solution-aware | Directly after the failed purchase and before the specification. A reader who once bought astaxanthin and felt nothing would leave at the first mention of it; here the narrator gets there first and doubts herself aloud. Her doubt earns the right to explain dose and form in entries 30 to 32. | The one truly human beat on the page: a shrug, a flat sentence, a question to herself. Four lines, none over eight words. It is shared almost word for word with the skin page, so the humanity is a component. The last line is a stock bridge. | keep-structure Keep the admitted limit. She took a low-dose softgel for a month and could not tell; she says so. Then the reason: the trials used more than most bottles give. b7c1 |
| 30 35.7% | differentiation img · p · 42 w | After a picture (not in the capture), one paragraph defines the right version by three traits: 12 mg, the natural algae form, and a fat carrier, said to carry it to the filter cells and across their membrane. | specificityreason-whyloop-closednew-mechanism solution-aware | The doubt in entry 29 asked whether the idea was wrong; the answer is that the idea was right and the bottles were not. The spec comes before any maker is named, so that when a product appears in entry 35 it is recognised as the thing already described. It also ties dose and form back to the membrane, the place of harm fixed in entries 19 and 22. | Forty-two words in two sentences, the first with a dashed aside. It reads like a label. The carrier is the weakest of the three traits and the page will lean on it hardest (entry 34). | rewrite-claim Our spec: 12 mg natural astaxanthin from Haematococcus pluvialis in one softgel, taken with a meal that has some fat. The carrier oil is never an argument (b8 is banned); fat is a how-to, not a superiority claim. b7c4r31b9 |
| 31 38.0% | mechanism p · 73 w | Astaxanthin is set apart from three antioxidants by where each one works; its long chain is said to be the right size to cross the whole cell membrane, held at both faces, where harm to a filter cell starts. | new-mechanismcontrastreason-whyloop-closed solution-aware | The cause was placed at the membrane twice before (entries 19 and 22) so that this paragraph could close on it. The three rival antioxidants are ones the reader already owns; putting each in its place first makes the fourth feel like the missing piece and not like a fourth pill. It has to come before the verdict on low doses in entry 32, which depends on it. | The page's best science writing: three short sentences of location, then one long sentence that mimics the thing it describes by stretching from one end to the other. Read aloud it works. It is the passage closest to how the molecule is described in the literature, and the one claim here that our own gate also holds. | swap-mechanism The Cell Shield, stated once in full: vitamin C stays outside cells, vitamin E rests on the membrane surface, astaxanthin's molecule spans the whole membrane. Kidneys, brain, eyes and joints are named as where that matters. The 6,000 times figure may follow as a spec. m2p3m3r5 |
| 32 39.4% | differentiation p · 62 w | A 62-word paragraph fails the shelf products on two counts: 4 and 6 mg capsules sit under the level at which tissue fills, and the synthetic kind, made from petroleum, is a different molecule from the one studied. | reason-whycontrastloop-closedobjection-preempt solution-aware | It answers the question she asked herself in entry 29, so it must follow the molecule and precede the maker. Once dose and source are the test, the reader cannot go to a marketplace and pick any astaxanthin: the page has shut the side door before showing its own product. | Three sentences, the last one 32 words and repetitive. The first two are crisp and each carries one fact. The dashed asides return. | rewrite-claim The same two tests, on gated facts: 12 mg clinical strength against the 4 to 6 mg brands, natural microalgae against synthetic made from petrochemicals, plus the category's failure rate in potency testing. Rivals are not named. b7c4r16c1 |
| 33 40.7% | product-reveal p · img · 24 w | She says she needed the genuine article, that speaking with a researcher was useful, that she located a laboratory in Ohio, went by car and observed the staff. A picture follows (not in the capture; by position, the laboratory). | story-transportearned-authorityspecificity solution-aware | With every shelf product disqualified, the reader asks where the right one comes from. A journey answers it better than a claim: she went and looked. It comes before any name or price so that the product is first met as a place and as work. | Fabricated: no laboratory is named and the visit cannot be checked. Five sentences of five, seven, five, three and four words; the pace is a car journey. One of them undoes the headline, since a top researcher would not need a researcher's help. | drop No invented lab visit. In its place, facts we can show: natural microalgae grown in closed bioreactors, and a third-party lab report for every batch, reached by the QR code on the front of the bag. c5c3c4 |
| 34 42.6% | product-reveal 2× p · img · 55 w | She describes notebooks of failed ratios and the formula in glassware as hope under test, then the months spent fixing the concentration and a coconut-oil carrier so the compound reaches the filters and stays put. Picture after (not captured). | reason-whystory-transportearned-authority solution-aware | Second step of the origin story. The reader has seen the laboratory; now they see that the right version is hard to make. This is the reason-why that the scarcity in entries 53 and 58 will draw on. It would be wasted after the offer. | Invented development story. The line about hope in a beaker is the one attempt at lyricism and it nearly works. The second paragraph withholds its main verb until its last three words. The carrier oil is given credit that the molecule had earned in entry 31. | drop Carrier-oil superiority is banned (b8) and the development story is invented. What can stand: the softgel is taken with a meal that has some fat, and each batch is tested by an outside lab before it ships. r31c3 |
| 35 45.2% | product-reveal 3× p · img · 15 w | Three terse lines declare success: the formula did its job, it is the studied compound at the studied dose, wholly natural, from algae, properly made. Picture after (not in the capture; by position, the first sight of the product). | loop-closedspecificityhope solution-aware | Forty-five percent. The reader has the cause, the molecule, the test for a good bottle and a place where one is made; the only thing missing is that it exists. Withholding the brand keeps this inside the story, and the reader's next question is not what it costs but what happened when she took it. | Three words, six words, six words. After the long science paragraphs the shortness reads as relief. The percentage claimed for natural content is an absolute that a label would have to prove. | keep-structure The noun is revealed here, by its full name: The Cell Shield, CellScience Astaxanthin 12 mg, one softgel. Product facts only from the PDP. The picture is the softgel and the bag with the QR code visible. b7c4c3b9 |
| 36 47.1% | turning-point 2× p · 14 w | She gives the weekday and the part of the day of her first dose, then a stock line promising that the sequel altered lives, in the plural. | open-loopstory-transportspecificity solution-aware | Between the product and the timeline. A weekday makes the dose an event in a life and not a step in a protocol. The plural in the second line is the first hint that others will follow her (entry 45). | The weekday is the detail; the second line is filler. Two variants of one stock phrase stand in adjacent rows here and in the subhead of entry 37, and a third stands in entry 17. | keep-structure One dated, ordinary moment: the first softgel with breakfast. No promise attached to it. b9r31 |
| 37 47.7% | how-to-use h2 · p · img · 15 w | A subhead repeats the weekday with a clock time and a claim of total change. One line gives the dose as two softgels and in the same breath as a single one, mornings. Picture after (not in the capture). | easespecificity solution-aware | Before the timeline, because results need a dose to be measured from. After eight years of diets, the smallness of the act is the selling point. Its closing two-word refrain returns at entries 42, 49 and 52. | The dose contradicts itself inside eight words, and the page never settles it (entry 42 says two a day). A reader who wants to comply cannot. The clock time in the subhead is a good touch wasted on a repeated phrase. | rewrite-claim One softgel a day with a meal that has some fat. It replaces nothing in her routine. Said once, the same everywhere. b9r31 |
| 38 49.5% | results-timeline h2 · p · 48 w | First rung, days one to three: slightly less puffiness in the face, fewer trips out of bed at night. She felt a change on the first day but held off judging whether it went as deep as the cause. | specificityhopecandorfuture-pacing solution-aware | The timeline opens with what the reader can see in a mirror or count at night, not with a lab value, because nothing on a chart moves in three days. Her own caution stands in for the reader's. Each rung from here is a little larger, which is what makes the lab result that tops the ladder (entry 42) feel reached and not claimed. | Forty-six words in a loose, spoken order, with a broken second sentence. The restraint is the craft: a small adverb, a wish to wait. An effect on the first day is still a large claim for a fat-soluble pigment that builds up over weeks. | rewrite-claim Our first rung is honest about speed: the first days, nothing to report, it builds in the cell over weeks. The first felt sign we may name is steadier energy in weeks one to two. r7 |
| 39 50.5% | results-timeline h2 · p · 51 w | Second rung, days three to seven: the evening swelling at her ankles recedes after two years, they feel ordinary on waking, she gains the nerve to continue and concludes it is working deeper than earlier remedies. | specificityreliefloop-closedcommitment solution-aware | Swelling was explained in entry 23 and is the sign the reader checks daily, so it is the right first real result. Its timing inside the first week matters for the offer: the refund checkpoints in entry 50 are built on this rung. | A two-word sentence repeats the verb of the one before it for emphasis, the way people talk. Forty-nine words, mostly short. The last sentence interprets the result for the reader, which is one sentence too many. | rewrite-claim No swelling outcome. Weeks one to two in our gate: no crash by noon. Told as one afternoon when she noticed she had not sat down. r7 |
| 40 51.6% | results-timeline h2 · p · img · 47 w | Third rung, days seven to fourteen: the afternoon haze lifts and mornings are sharper. She photographs the toilet bowl once the foam of two years has gone, and keeps the picture. Image after (not captured; by position, that photo). | specificitycandorreliefpattern-interrupt solution-aware | Placed mid-ladder, after the polite symptoms. A reader who has the sign and has told no one is now certain the narrator is real. Earlier it would have been too intimate; later it would be lost behind the lab values. | The saved photograph is the most convincing detail in the timeline because it is slightly embarrassing. The coined phrase for tiredness is a marketer's, not a patient's. Three sentences about her head and her energy, two about the bowl, and the bowl wins. | rewrite-claim The gate holds the foam line (r11) but the angle flags it: structure and function only, no disease word, no photograph of a result. The safer rung here is eye strain easing in 14 to 28 days, or the fog lifting. b6r6r11 |
| 41 54.2% | results-timeline h2 · p · 46 w | Fourth rung, days fourteen to thirty: after a week free of the afternoon slump she asks her husband what he has seen; he has seen nothing, and she counts that as the proof. Ankles normal each morning. | specificitystory-transportreliefsocial-proof solution-aware | By the fourth rung the reader has only her word. A second person is needed before the lab values arrive, and a husband who notices nothing is more credible than one who marvels. It also resets the reader's expectation: improvement may feel like nothing happening. | Her one-word reply is the best line on the page: a result expressed as a non-event, with a joke in it. The sentence that follows is its opposite, a 14-word clause of lab vocabulary in the mouth of the same woman. | keep-structure Keep the witness who noticed nothing: a spouse or daughter who cannot name what changed, only that the afternoons are ordinary. Energy and a clear head only. r7r6 |
| 42 55.3% | results-timeline h2 · p · img · 69 w | Top rung, month two: score 54 where it had been 41, waste marker down, urine protein gone, inflammation lower, same drug dose; her kidney doctor is quoted declining to write a referral; she keeps her subscription. Picture after (not captured). | specificityborrowed-authorityreliefloop-closed solution-aware | Last rung, 55 percent in. Everything before it was felt; this is measured, and the reader who came for a lab value gets four. It closes the headline's loop, which frees the remainder of the page to sell. The second half of the doctor's remark returns unchanged in entry 69. | Fabricated lab values and a fabricated physician's remark; the baseline will change to 39 in entry 66. Set as a list of marker, colon, result, it reads like a report card. The quoted doctor is wry and believable. A subscription is mentioned although no plan has ever been offered. The refrain closes the entry. The picture under it, not in the capture, stands where a lab sheet would be shown. | drop No lab values, no quoted physician, no dialysis, no subscription (we have none). In this place: the drifting-to-steady numbers card with no figures on it, and her plain line that she went to her next panel having done something in between. r10 |
| 43 58.2% | future-pace h2 · 8 w | A subhead addresses the reader directly and promises that the talk of dialysis can be ended for good, with the key phrase highlighted. | hoperelieffuture-pacing solution-aware | Immediately after her lab values, while they are fresh. It is the first time since the opening that the page speaks to a you, and it marks the turn from her story to the reader's decision. Made before the results it would be an empty claim; here it borrows their weight. | Eight words, one of them an absolute set apart as its own sentence. It is the largest claim on the page and the one most likely to get an ad account closed. As writing it is clean. | rewrite-claim Our turn to the reader promises an action, not an outcome: something she can do between two panels. Organs named, no disease word, no forever. r10b9 |
| 44 58.6% | proof-social p · img · 19 w | She says she then took a step that would either confirm her or make a fool of her. A picture follows (not in the capture; by position, her own post sharing the find with the group). | open-loopstory-transportcandor solution-aware | One woman's result, however measured, is an anecdote. The reader's next doubt is whether it works for anyone else, and the page raises the stake on her behalf before answering. It returns to the forum of entries 10 to 13, which by now the reader regards as neutral ground. | Nineteen words with a real either-or in them. The act itself is left to the picture, so the text never says what she did. | rewrite-claim She tells two friends from her walking group, or her sister. Small, checkable, human. No forum post. |
| 45 59.8% | proof-social 4× p · 36 w | A rising count: forty people try it inside a week and none disputes her; the identical outcome more than sixty times; the three results restated on an unchanged drug dose; then a two-word line jumping to four thousand. | social-proofconsensusspecificity solution-aware | It answers the doubt about other people raised one entry earlier, and it must precede the choice of paths in entry 46, which leans on the crowd. The final jump roughly matches the ratings count under the headline (entry 6), a loop most readers will feel without noticing. | Invented counts. Sixty results from forty people does not add up. The escalation is well paced, 15 words, 7, 12, then 2, and the last line lands because it is so short. No person is named, quoted or pictured: the proof is arithmetic. | swap-proof Real proof only: the published human trials on skin and eyes named as such, the count of clinical studies, and customer numbers as a specific four-digit figure once they exist. Panel statistics wait for sign-off. r14b1b3r17 |
| 46 61.1% | close h2 · p · 54 w | A subhead offers two options. The first is listed at length: more pills, more visits, water tablets, pressure drugs, higher doses, three prescriptions for one unnamed problem. The second takes one line: do what 41,847 others did. | contrastloss-aversionconsensuscommitment solution-aware | At 61 percent the evidence is in and no price has been shown. The reader is asked to choose a path before being asked to buy a product, a smaller yes. The forum's number is reused as a count of people who took the second path, so the crowd from the page's first screen is now on the seller's side. | The first option is an opening sentence and six fragments that pile up like the prescriptions they list; the second is a single calm sentence. The imbalance is the argument. The count has changed meaning again without comment. | keep-structure Two paths in her terms: wait for the next panel and change nothing, or do one small thing in between. Her medicines are never the bad path. No head count. r10b9r23 |
| 47 62.7% | guarantee 2× p · 62 w | A disclaimer of hype, then the terms: ninety days with Rovina (the brand's first appearance in the body), and money returned without questions, even for an empty bottle, if score, swelling and referral are unchanged. | risk-reversalcandorspecificityobjection-preempt solution-aware | Sixty-three percent. The name has been withheld through cause, molecule, maker and results; it is released only when the reader has chosen a path, and it arrives wrapped in a refund. The conditions are the three complaints of entry 7, so the guarantee reads as a promise about the reader's chart, not about a bottle. | A clause has dropped out of the second sentence, leaving a dash where the condition should start. The three conditional clauses build well. The disclaimer, set in title case, is itself hype. Tying a refund to a lab score is a promise of outcome that no supplement advert could lawfully make. | swap-offer The noun first named with the guarantee beside it: try The Cell Shield under the 30-Day Money-Back Guarantee, full refund, keep the bag (BRAND.md section 3; one name and one window everywhere, CL-09; the 30-day lock replaced the 90 days of r22). The conditions are hers to judge, not lab values. |
| 48 63.8% | offer p · img · 15 w | She states a total of over 14,000 dollars spent across eight years, then a fragment pointing to this single tool, with no price attached. A picture follows (not in the capture; by position, the product). | anchoringcontrastloss-aversion product-aware | Right after the guarantee and before the ordering steps, where a price would normally stand. The page withholds the price from the article altogether and lets the anchor do the work alone; the reader meets the actual figure only on the product page, after the click. | The second sentence is broken: it ends where a price or a verb should be, a hole left by the template. The anchor contradicts entry 16 by 8,000 dollars; it is the skin page's figure, left in place. A reader who noticed would stop trusting every other figure. | swap-offer A real anchor and a real price, read from the live store: one bag 29.99, three bags 59.97, five bags 89.95, free shipping, against the 59.99 retail anchor. On a prelander the price may stay on the PDP; if shown, it mirrors the PDP exactly (CL-10). x4 |
| 49 65.3% | future-pace h2 · 3× p · 95 w | The sequence after ordering, step by step. Today: click, pick a supply, a confirmation email in three minutes, look in spam. Two days: it leaves the Ohio lab with tracking. On arrival: two softgels each morning, prescription untouched. | easefuture-pacingspecificityobjection-preempt product-aware | After the guarantee and the anchor, before the scarcity. The reader has decided in principle; what stops an older buyer now is the procedure: will it arrive, will I know, does it sit alongside my pills. Answering those in order of time turns a purchase into a schedule. It also plants the instruction to stay on medication, which protects the seller. | Capital time stamps start each paragraph and the sentences are as short as the steps. The note about the spam folder is the kind of detail only a real support inbox teaches. The container is a jar here and a bottle in entries 47 and 60. The refrain returns. | keep-structure Keep the walkthrough whole, with our facts: order today, confirmation by email, ships with tracking, one softgel a day with a meal that has some fat, keep taking what the doctor prescribed and ask about blood thinners first. b9r31r28 |
| 50 67.8% | results-timeline 3× p · 118 w | The ladder again, in the second person, tied to the refund. Days three to seven: less puffiness. Day fourteen: inspect the ankles, or write for a refund. Day sixty: a panel with two extra markers, or a refund. | risk-reversalfuture-pacingcommitmentspecificity product-aware | It repeats the narrator's ladder (entries 38 to 42) as the reader's own calendar, which only works once the reader has seen it succeed. Each date carries a way out, so the purchase feels like an experiment with an exit at every stage. Telling the reader which markers to request makes them a participant and brings their doctor in as the judge. | The strongest structural idea on the page, in plain imperative sentences. The softening verb in the first paragraph is the only hedge on a result in 2,800 words. Naming two markers beyond the usual one is insider knowledge that flatters the reader. The lab promise at day sixty is a claim of outcome. | rewrite-claim Keep the dated self-test, inside our 30-day window and our gate: weeks one to two, energy; days 14 to 28, eye strain; day 30, decide. The panel is months away, so it cannot be the refund checkpoint; she takes her results to her doctor as usual. r7b6r10 |
| 51 70.1% | offer p · 56 w | A bonus announced as an afterthought: a guide to week one, sent by email, answering three quoted customer questions (with a pressure drug, with a water tablet, at what hour). It repeats the advice to stay on medication. | objection-preempteasesocial-proof product-aware | After the calendar, since the questions it lists are the ones a reader forms while imagining the first week. Framing them as what everybody asks makes the worry normal. It sits before the scarcity so the reader's last practical objection is cleared before pressure is applied. | Fifty-six words. The three questions are in the customer's voice and in quotation marks, the first quoted customer speech on the page. The guide is hers, a possessive that confirms she is the seller. | swap-offer Our bonus is gated: three free digital guides with every order. The interaction questions are answered on the page itself in the FAQ, with the blood-thinner caution. r20r28r27 |
| 52 71.3% | offer 2× p · 29 w | A recap of the product as a single thing with nothing added, no further pills and no fillers, only the 12 mg natural compound at the right concentration and carrier. Then a one-line warning that something must be known first. | easespecificityopen-loop product-aware | The reader has been told how to order, what will happen and what comes free; a recap lets them hold the whole offer in one sentence. The bridge line that follows is the hinge into scarcity: the page has been generous for ten percent and is about to take something away. | The refrain opens the entry, its fifth use on the page. Two denials in fragments, then the spec. The bridge is a stock setup line ending on a colon. No price, size or count of softgels is given in a recap of the offer. | keep-structure Our recap: one softgel a day, 12 mg natural astaxanthin, thirty softgels in a bag, nothing she has to stop taking. One product instead of juggling a drawer. b9b7c4r23 |
| 53 72.2% | urgency h2 · img · p · 43 w | A subhead sets the maker against the big marketplace and says batches are small. After a picture (not captured), the numbers: only the Ohio lab makes it correctly, 2,400 jars per six-week run, closed when sold, 847 left now. | scarcityurgencyreason-whyexclusivity product-aware | At 72 percent, after every practical question is settled and just before the first button. The laboratory story of entries 33 and 34 is cashed in here: because it was hard to make, there is little of it. Scarcity stated before that story would be a sales trick; after it, it is a consequence. | Fabricated count: the remaining number is typed into the page and cannot move. The odd figure is chosen to look counted. The subhead is eight words and the comparison to the marketplace is the sharpest positioning line on the page. One sentence uses a verb for shutting that does not fit jars. | drop No invented stock count. Honest urgency only: the launch-week code with its real end time, and the official-site-only line. If a batch is truly limited, the number comes from inventory. r29x4 |
| 54 74.5% | stakes 4× p · 44 w | Two questions for the reader: can they bear six more months of a falling score and rising swelling, and can they bear to accept the referral their doctor now treats as unavoidable. Two noes lead to the button. | loss-aversionfear-of-declinecommitmenturgency product-aware | The last lines before the first button. Scarcity gave an outside reason to act; this gives the inside one. Six months is the usual gap between panels, so the question is about the reader's actual next appointment. The conditional sentence leaves the reader in mid-thought with only the button to finish it. | Both questions open with the same four words and run to 16 words each, a matched pair. The second overstates: no earlier line said the referral had become compulsory. Ending the block on a colon is efficient. | rewrite-claim One question, no fear: the next panel is six months away; does she want to arrive having done something. No decline threatened, no referral. r10 |
| 55 75.9% | cta cta · p · 24 w | The first button, at 76 percent of the page, names the brand and the ninety-day guarantee. Under it, a balanced line: a refund if it fails, a life returned if it succeeds. | risk-reversalcontrasthope most-aware | Three quarters down. The page spends its length earning one button and then shows five more in the last quarter. The guarantee is on the label because at this point the reader's remaining fear is waste, not doubt. The line below restates the two paths of entry 46 as two outcomes. | Five words and a dash on the button, the last three the guarantee. The support line is a mirrored pair, 18 words, and it is the kind of sentence people repeat. This button says get; three of the five that follow only say check. | swap-offer One CTA vocabulary for the funnel (CL-16), the noun on the button where it fits, and the guarantee by its one name: 30-Day Money-Back Guarantee. |
| 56 76.6% | close 3× p · 25 w | A short afterthought returns to the forum, now named as a Reddit thread, and says two hundred newcomers arrive there weekly on the same search, which the reader has already completed. | loop-closedconsensusexclusivity most-aware | Just after the first button, for the reader who did not click. It reuses the one device the reader trusted, the thread, and changes their position in it: from one of the lost to the one who holds the answer. That flatters without pushing, and sets up the queue-number close at entry 64. | Three lines of 3, 13 and 9 words. The last sentence is three words and is the best close on the page. The platform is named for the first time here, almost seventy points after the thread was introduced. The weekly figure is invented: the skin page gives the same figure for a thread on a different platform. | keep-structure A callback to our own opening image: the recheck date on the calendar. She does not have to spend the months in between only waiting. No forum, no weekly count. r10 |
| 57 77.5% | cta cta · 5 w | Second button, worded as the start of a ninety-day trial, with an arrow. | commitmentrisk-reversalease most-aware | It follows the callback within one row. The first button asked the reader to get a product; this one asks them to begin a trial, which matches the dated self-test of entry 50 and is an easier thing to agree to. | Four words and an arrow. Its noun is the right one for a sceptic. Two differently worded buttons a few rows apart suggest the labels are being tried against each other. | swap-offer The same idea in our window: start the 30-day trial of The Cell Shield. One label per funnel once chosen (CL-16). |
| 58 77.9% | urgency p · img · 78 w | A 78-word postscript answers a customer who asks, using her first name, why output is not raised: they tried, the formula resists mass production, only the Ohio lab gets it right, checking sets the pace. Picture after (not captured). | reason-whyscarcityobjection-preemptcandor most-aware | A postscript is read by people who skipped everything above it, so it restates the one thing that makes acting today rational. It answers the sceptic's thought (if it sells, make more) before the availability button directly beneath it. Without this, that button's label would sound like a gimmick. | The quoted question with her name in it is a letter-writer's device and sounds like speech. The last sentence runs to 28 words and loses its grip halfway. The position is odd: a postscript in the middle of the closing section, with 22 percent of the page still to come. | rewrite-claim A reason-why we can stand behind: every batch goes to an independent lab before it ships and the report is on the bag. No claim that supply is capped unless it is. c3c5 |
| 59 81.0% | cta cta · 2 w | Third button, two words in capitals, inviting the reader to see whether stock remains. | scarcitycommitmentcuriosity-gap most-aware | Directly under the postscript about limited output, which is the only reason the label makes sense. Looking is a smaller act than buying, so the reader who refused two purchase buttons may still press this one. The label is reused at entries 65 and 72. | Two words. It asks a question the page has already answered (847 left), so the label is theatre, but effective theatre. It leads to the same product page as every other button. | drop No availability check when stock is not limited. Our button names the action and the noun. |
| 60 81.4% | guarantee h2 · 3× p · 35 w | A subhead tells the reader they have been let down 147 times and promises a difference. Terms in fragments: ninety days, money back in full, bottles kept, a refund by email at any moment, day 100 among the examples. | risk-reversalobjection-preemptmirroringspecificity most-aware | At 81 percent, for the reader who passed three buttons. Their remaining objection is no longer the product, it is themselves: they have believed before. The subhead names that, and the terms answer it. The first statement of the guarantee (entry 47) was tied to results; this one is unconditional. | The count of disappointments is absurdly exact and nobody could know it; it reads as a placeholder that was never edited. The example of day 100 falls outside the ninety days. Here the customer keeps the bottles; in entry 47 the seller takes one back. The fragments are punchy. | swap-offer The same second pass, for the burned buyer, with our terms stated once and identically: 30-Day Money-Back Guarantee, full refund, keep the bag. No count of her past purchases. |
| 61 82.8% | guarantee 3× p · 40 w | Empathy for the reader's past losses, in the company's plural voice, then a statistic: two refund requests out of 41,847 in three years, both paid inside a day. A final line reduces the deal to working or costing nothing. | social-proofrisk-reversalspecificityidentification most-aware | It follows the terms, because a guarantee raises the question of how often it is claimed. The answer is meant to say the product works; placed before the terms it would have no meaning. | Fabricated and self-defeating: a refund rate of two in forty thousand is less believable than no figure at all, and the denominator is the forum's headcount from entry 10 and the deck's study size from entry 5. The voice has moved from I to we. The last line is a clean either-or. | drop No refund statistic. The guarantee stands on its terms. Proof of trust is the batch lab report on the bag, which she can scan before she buys. c3 |
| 62 83.8% | proof-social 3× p · 32 w | A sentence in the third person reports that she expected one message above all, the fear that it would fail for the writer, and that nobody ever reported failure. Two lines from entry 45 are then repeated unchanged. | objection-preemptsocial-proofconsensus most-aware | It sits where the reader's last private objection lives, after the guarantee and before the final appeal, and the intention is sound. The objection is handled properly later, in the letter (entry 70). | The narrator is suddenly a she: a paragraph written about her was pasted into a page written by her. The two repeated lines were strong once and are dead the second time. This is the weakest entry on the page and the clearest evidence that blocks were assembled, not written. | drop Nothing stands here. The exception fear is answered once, in the narrator's own voice, near the close. No sentence appears twice on one page. |
| 63 84.9% | future-pace 3× p · 64 w | One 50-word sentence meets the reader in three ongoing situations and says they can be the next one the thread finds, numbers restored. A three-word line adds two days. Then: click to see whether an allocation remains. | future-pacingidentificationhopescarcity most-aware | Eighty-five percent. The arguments are finished; what remains is to make the reader feel addressed. The three situations repeat the opening mirror in the present tense. The line about allocation prepares the fourth button. | Three clauses beginning with the same word give the long sentence its beat. The two-day line is placed so that it seems to promise numbers restored within two days, when it can only mean shipping: an overclaim made by layout. The rationing noun in the last line is well chosen. | rewrite-claim The three situations in our terms (told to watch it, told to come back in six months, feeling fine and unsure), then what she can start this week. Delivery time is stated as delivery time. r10b9 |
| 64 86.6% | close 2× p · 7 w | Two lines: the forum's count plus one is said to be waiting, and the reader is told that person is them. | identificationconsensusloop-closed most-aware | The number has appeared four times; adding one to it is the payoff of the motif, and it only works at the end. It comes straight before a button, so the reader's next act completes the count. | Five words, then two. The arithmetic is the whole device and it is neat. It also confirms that the forum, the customer base and the study were always the same invented number. | drop No invented count to add one to. If we close on belonging, it is to a real customer number (four digits, CL-11). |
| 65 87.1% | cta cta · 2 w | Fourth button, the same two capitalised words as the third. | scarcitycommitment most-aware | Placed directly under the line that names the reader as next in line, so checking stock reads as taking one's place. It is the last button before the letter. | Identical label to entry 59, so nothing new is learned from it. | drop As entry 59: our button names the action and the noun. |
| 66 87.4% | proof-social 3× p · 49 w | A letter begins: 127 days earlier the writer stared at this button for twenty minutes, thinking she alone keeps falling for failures and could not bear another; her score was 39, a referral ready for two years. | mirroringidentificationstory-transportobjection-preempt most-aware | Eighty-seven percent, for the reader who has passed four buttons. Argument has failed with this reader; only a person in the same chair can move them. The scene is the button itself, so the letter describes the reader's present moment as someone else's past. | The strongest opening line in the closing section. But the letter is a customer's, and it will be signed by the narrator, who made the product and could not have hesitated over buying it. Her baseline was 41 in entry 42. The same letter, with the same day count and the same stare, closes the skin page under another name. | rewrite-claim Keep the scene at the button, told by the narrator in her one consistent role as a customer. Her doubt: one more bottle for the drawer. No score, no referral. r23 |
| 67 88.7% | proof-social 2× p · 22 w | She records the opposing thought, that the present state could not continue, and then the act: she pressed the button with trembling hands, sure it was an error. | identificationstory-transportcommitment most-aware | Second beat of the letter. The hesitation was matched in entry 66; the reader now needs to see that one can act while still doubting. It must precede her results, or the results would read as the reason she clicked. | Three fragments for the act, of three, two and seven words. The adverb in the last one is wrong for the sentence and nobody would say it. The thought before it is plain and good. | keep-structure She orders one bag, half expecting nothing. The guarantee is why she can. Told in two plain sentences. |
| 68 89.3% | results-timeline 2× p · 77 w | Her results, first two rungs. Day seven: ankle swelling lower than at any point in two years, checked three times. Week six: two flights of stairs at work, no exhaustion, half a minute standing still, a text to her sister. | specificitystory-transportreliefhope most-aware | The earlier ladder (entries 38 to 42) was a list of symptoms by date; this one is two moments in a life. It comes late because it is the emotional version, and by now the reader has the facts and needs the picture. The sister is the second witness after the husband. | The staircase scene is the best writing on the page: short sentences that stop where she stops, and a text message whose meaning the sister understands without being told. Checking three times is how disbelief behaves. The workplace puts her at working age, younger than the reader the page is courting. | keep-structure One scene of ordinary capacity for a reader in her sixties or seventies: the stairs to the church hall, the walk back from the shops without stopping. Energy and steadier afternoons only. r7r24 |
| 69 90.8% | results-timeline 2× p · 82 w | Twelve weeks: score 54, having started at 39, on the drug of six years; the kidney doctor looks from page to patient and repeats the referral line. Then small gains: meals without arithmetic, visits without dread, one problem, not three. | specificityborrowed-authorityreliefloop-closed most-aware | Top of the letter's ladder. The lab values come before the small things because the small things are what the reader actually wants and the values are what permits wanting them. The closing phrase about three problems being one returns the page's central idea in the customer's mouth. | Fabricated, and inconsistent with entry 42: a different baseline, a different week, and a drug history two years shorter than in entry 20. The doctor's double take is staged well in three short sentences. The paragraph of small things uses three parallel negatives, and the last one is a slogan. | drop No values and no physician's verdict. Keep only the small things, rewritten as capacities: planning a trip, not dreading the envelope, one softgel instead of a drawer. r24r23 |
| 70 92.3% | objection 2× p · 30 w | She says she cannot know the reader's position, guesses it is the tunnel she knew, and voices the reader's likely thought that she was fortunate and they will not be. She answers in four words that she believed the same. | objection-preemptidentificationcandor most-aware | After the results and before the sign-off, since results are what provoke the thought. Entry 62 tried to answer it with a claim that nobody fails; this answers it by admitting she had the same doubt, which is the only reply the reader cannot argue with. | Twenty-six words of setup and four of reply. The reply is the right length. The tunnel sentence ends on the wrong verb, a slip the skin page does not have. | keep-structure Keep exactly this exchange in her voice: maybe the reader thinks it helped her and will not help them; she thought so too. No claim follows it. |
| 71 93.1% | close 3× p · 26 w | She repeats the 127 days, says she now has a life she had forgotten was possible, tells the reader she will be there whatever they choose, and signs with her first name after a dash. | hopefuture-pacingidentificationloop-closed most-aware | Last words of the letter, 93 percent down. The line about being there removes pressure at the moment the page has applied most of it, which makes the final buttons feel like the reader's own idea. The signature ties the letter to the byline of entry 6. | The repeated day count frames the letter. The penultimate line is gentle and well judged. The signature is where the roles collide: the maker signs a buyer's letter. | keep-structure Sign-off by the same narrator who opened, first name only, composite disclosed in the footer. The line that leaves the choice with her stays. |
| 72 94.0% | cta cta · 3 w | Fifth button: the availability label again with one word added to point at the spot. | scarcitycommitment most-aware | Directly under the signature, where a reader moved by the letter looks next. The label has not changed since entry 59, so the button relies entirely on the letter above it. | Three words. The added word is furniture. | swap-offer Our button after the letter names what she gets: The Cell Shield, with the guarantee by name. |
| 73 94.6% | offer 3× p · img · 60 w | A notice dated June 2026 says demand has jumped, and offers 67 percent off with fast shipping; a second line repeats it; a note says the deal exists nowhere else. Product picture beside it (not captured). | urgencyscarcityexclusivityanchoring most-aware | Below the story, as a separate block in a different voice. Keeping the discount out of the article protects the article's pose as testimony; putting it last rewards the reader who finished. It pays off the bar of entry 1. | The voice is a store's, with capitals for the deal. A percentage with no price and no original price anchors to nothing. The notice is dated seven months after the byline, the one sign that the page is maintained. The reason given for urgency is demand, which explains scarcity but not a discount. | swap-offer Our offer block, prices read from the live store: three bags 59.97 as the default, five bags 89.95 as the lowest price ever, one bag 29.99, free shipping, official site only, launch code banner. x4r29 |
| 74 97.3% | guarantee 2× img · 3× p · 9 w | Two icons with labels: a ninety-day refund promise, split over two lines, and delivery that is quick and costs nothing. | risk-reversalease most-aware | Under the offer, where a store would put them. They repeat in a few words each what the article took paragraphs to argue, for the reader who scrolled straight to the bottom. | Stock badge copy; the skin page carries the same four. The icons have no alt text. | swap-offer Our badge row: 30-Day Money-Back Guarantee, free shipping, and the gated trust marks (cGMP, Made in USA, gluten-free, no stimulants). r18 |
| 75 98.4% | guarantee 2× img · 2× p · 8 w | Two more icons with labels: a checkout described as protected, and returns described as painless. | risk-reversalease most-aware | Last reassurance before the last button. Payment safety is the one fear the article never addressed, and it matters to an older buyer. | Stock labels. The first says the same thing in three adjectives. | page-furniture The standard checkout trust row from the template; returns wording must match the guarantee's one name. r18 |
| 76 99.5% | cta cta · 5 w | Final button, in capitals, combining the 67 percent discount with the brand name and an instruction to act at once. | urgencyanchoring most-aware | Bottom of the page, under the offer block, where the reader has just met the discount for the first time. After five buttons about guarantee, trial and availability, the sixth tries money. | Five words. It is the first button whose label gives a reason to click that is not already in the story. | swap-offer The final button carries the noun and the real saving from the live store, in the funnel's one CTA vocabulary. x4 |